PERSPECTIVE THERAPEUTICS, INC.
Ownership & governance
Executives 5Directors 6Avg age 59Avg tenure 2.7y
JS
Johan Spoor
Chief Executive Officer
Age 54Since 2023-02-04Profile →
+10
Executives5
Board of directors6
JS
Johan Spoor→
Director/Board Member
Age 54Since 2023-02-04
LW
Lori Woods→
Chairman
Age 63Since 2023-02-02
RW
Robert Williamson→
Director/Board Member
Age 60Since 2023-02-04
FM
Frank Morich→
Director/Board Member
Age 71Since 2023-02-04
HH
Heidi Henson→
Director/Board Member
Age 60Since 2023-05-31
MM
Maya Martinez-Davis→
Director/Board Member
Age 56Since 2025-09-02
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| LANTHEUS HOLDINGS, INC. | 10.24 % | 11,677,339 |
| TCG Crossover Management LLC | 6.941 % | 7,915,567 |
| TCG Crossover Management LLC | 6.941 % | 7,915,567 |
| Qatar Investment Authority Advisory (USA), Inc. | 6.202 % | 7,073,308 |
| Commodore Capital LP | 5.556 % | 6,336,782 |
Catalog · 2026-07-09
Registry officers11
| Name | Role | Since | Shares |
|---|---|---|---|
| David Hauser | Chief Tech/Sci/R&D Officer | 2022-03-31 | - |
| Joel D. Sendek | Director of Finance/CFO | 2025-09-03 | - |
| Johan Spoor | Chief Executive Officer | 2023-02-04 | - |
| Lori Woods | Chairman | 2023-02-02 | - |
| Markus Puhlmann | Chief Tech/Sci/R&D Officer | 2023-02-02 | - |
| Michael Schultz | Chief Tech/Sci/R&D Officer | — | - |
| Frank Morich | Director/Board Member | 2023-02-04 | - |
| Heidi Henson | Director/Board Member | 2023-05-31 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus strong buyMean target 12.29Range 5–18Analysts 14
5Mean 12.2918
- Strong buy 2
- Buy 13
- Hold 1
Broker actions40 of 65
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| BTIG | Reiterated | Buy | 14 | 2026-10-07 |
| William Blair | Initiated | Outperform | — | 2026-09-18 |
| Wedbush | Reiterated | Outperform | 11 | 2026-09-15 |
| BMO Capital | Initiated | Outperform | 11 | 2026-08-19 |
| B of A Securities | Maintained | Neutral | 5 | 2026-08-14 |
| Piper Sandler | Maintained | Overweight | 14 | 2026-08-11 |
| Wedbush | Reiterated | Outperform | 11 | 2026-05-05 |
| Wedbush | Reiterated | Outperform | 11 | 2026-04-20 |
| HC Wainwright & Co. | Maintained | Buy | 13 | 2026-03-23 |
| B. Riley Securities | Maintained | Buy | 13 | 2026-03-18 |
| UBS | Maintained | Buy | 8 | 2026-03-18 |
| Wedbush | Reiterated | Outperform | 11 | 2026-03-18 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.